Latest Reports

The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.

This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.

The “2025 Exudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of anti-VEGFs and other therapies for exudative retinal diseases. It highlights key market trends, growth drivers, and future opportunities, with five-year forecasts in units and dollars for branded ocular anti-VEGFs, cancer drugs used off-label, biosimilars, and sustained-drug-delivery devices. The report also breaks down market share by product category and profiles 29 leading competitors, detailing their products, strategies, and market positioning. 

The “2025 Premium Cataract Surgery Market Report” delivers a clear view of the world’s leading PCS markets, covering 13 countries that together generate 84 percent of global PCS manufacturer revenue. From the United States and China to Japan, Germany, and beyond, each market is analyzed in depth, highlighting key trends, growth drivers, and strategic opportunities. 

The report zeroes in on the factors that matter most for companies evaluating market potential or planning to launch premium cataract surgery devices, providing actionable insights to guide investment and expansion decisions. 

The “2025 Nonexudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of current and emerging therapies for geographic atrophy, dry AMD, and other nonexudative retinal diseases. It evaluates complement inhibitors, gene therapies, sustained-release technologies, antioxidants, and more—examining key market trends, patient economics, reimbursement dynamics, and five-year growth forecasts.  

The report also includes detailed unit and dollar demand projections, product category market shares, and profiles of 19 leading competitors with insights into their strategies and outlooks. 

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Market Report” is the definitive resource for understanding the global ophthalmic diagnostic landscape. This edition delivers in-depth analysis of the current markets for diagnostic equipment in cataract and refractive surgery, refracting and screening instruments, and emerging technologies. It also provides five-year global forecasts, along with regional and economic analyses across the US, Western Europe, Japan, other wealthy nations, China, India, Latin America, and developing markets worldwide. 

The report considers more than 800 devices from 115 manufacturers, covering technologies that span corneal topographers, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and advanced microscopy systems. 

Each section includes market sizing, pricing trends, competitor market share, installed equipment base, and company profiles, giving manufacturers, investors, and eye care providers the actionable intelligence needed to navigate competitive dynamics, plan strategic growth, and anticipate technological innovation.  

The 2025 Refractive Surgery Market Report provides a comprehensive view of the global refractive and presbyopia-correcting surgical market, highlighting the trends, drivers, and opportunities shaping the next five years. The report analyzes LASIK, lenticular extraction, phakic IOLs, refractive lens exchange (RLE), and emerging technologies poised to disrupt the market. 

It examines key participants in this segment, including prospective patients, refractive surgeons, laser centers, manufacturers of excimer and femtosecond lasers, mechanical microkeratomes, diagnostic equipment, and other presbyopia-correcting technologies.  

The report provides unit and revenue forecasts, market share analysis, and in-depth profiles of 15 leading competitors, including product portfolios, strategic positioning, company background, and outlook. 

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

The “2025 Glaucoma Surgical Device Market Report” provides a data-driven analysis of the global market for glaucoma surgical devices, offering comprehensive coverage of current technologies, innovation pipelines, competitive positioning, and growth opportunities by region. 

The report examines global glaucoma prevalence and treatment trends. It details the full spectrum of commercialized devices—including microstents, subconjunctival shunts, canal surgery devices, and tube shunts—and evaluates the pipeline of investigational products that are poised to improve outcomes and drive future adoption. 

Market demand is forecast in both units and dollars through 2030, with detailed segmentation by device category, procedure type, and region. Competitive analysis includes market share estimates, plans for product adoption, and detailed profiles of 29 leading and emerging companies, highlighting their products, strategic positioning, and outlook in this rapidly evolving segment. 

The “2025 Ophthalmic Surgical Instruments Market Report” delivers a comprehensive analysis of the global market for reusable and disposable ophthalmic surgical instruments, with forecasts through 2030. This edition examines the latest market trends, technology shifts, and competitive dynamics shaping the future of ophthalmic surgery worldwide. It includes a comprehensive overview of ophthalmic procedures and surgical volumes, with a special focus on cataract surgery—the most frequently performed ophthalmic procedure globally.

Product demand is projected in both units and dollars, with detailed market share analysis across key product categories. The report profiles 29 leading competitors, exploring their products, strategic positioning, and growth outlook, while also identifying 83 companies actively participating in this market segment.